 |
Transforming growth factor-beta 2 |
|---|---|
| Trade Name | |
| Orphan Indication | Full thickness macular holes |
| USA Market Approval | USA |
| USA Designation Date | 1992-12-18 00:00:00 |
| Sponsor | Celtrix Pharmaceuticals, Inc.;3055 Patrick Henry Drive;Santa Clara, California, 95054 |
